Atlas Trials

Effect of Intrapulmonary Recombinant Human Activated Protein C (APC) on Coagulation and Inflammation After Lipopolysaccharide (LPS)

Clinical trial NCT00943267 · COMPLETED

Trial details

NCT number
NCT00943267
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
PneumoniaLipopolysaccharides
Start date
2008-10-01
Primary completion
2010-08-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.